Plasma cotinine levels and pancreatic cancer in the EPIC cohort study.

Authors:

Leenders M, Chuang SC, Dahm CC, Overvad K, Ueland PM, Midttun O, Vollset SE, Tjønneland A, Halkjaer J, Jenab M, Clavel-Chapelon F, Boutron-Ruault MC, Kaaks R, Canzian F, Boeing H, Weikert C, Trichopoulou A, Bamia C, Naska A, Palli D, Pala V, Mattiello A, Tumino R, Sacerdote C, Duijnhoven FJ, Peeters PH, Gils CH, Lund E, Rodriguez L, Duell EJ, Pérez MJ, Molina-Montes E, Castaño JM, Barricarte A, Larrañaga N, Johansen D, Lindkvist B, Sund M, Ye W, Khaw KT, Wareham NJ, Michaud DS, Riboli E, Xun WW, Allen NE, Crowe FL, Bueno-de-Mesquita HB, Vineis P.

Source:

Int J Cancer 2012; 131: 997-1002. (IF 6.198)

This website only uses technical cookies and does not collect personal data or use profiling cookies. By continuing to browse, you accept the use of cookies.